Correlation between MTHFR gene methylation and pre-eclampsia, and its clinical significance

Genetics and Molecular Research

Volumn 14, Issue 3, 2015, Pages 8021-8028

  Ge, J ^a   Wang, J ^a   Zhang, F ^a   Diao, B ^a   Song, Z F ^a   Shan, L L ^a   Wang, W ^a   Cao, H J ^a   Li, X Q ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Hcy; Methylation; MTHFR; Pregnancy hypertension

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; GENOMIC DNA; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ADULT; AGAR GEL ELECTROPHORESIS; AMINO ACID BLOOD LEVEL; ARTICLE; CHEMOLUMINESCENCE; CHINA; CONTROLLED STUDY; CORRELATIONAL STUDY; DNA EXTRACTION; DNA METHYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MTHFR GENE; PLACENTA; POLYMERASE CHAIN REACTION; PREDICTION; PREECLAMPSIA; PROMOTER REGION; VITAMIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; PREGNANCY;

ADULT; CASE-CONTROL STUDIES; DNA METHYLATION; ELECTROPHORESIS, AGAR GEL; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMERASE CHAIN REACTION; PRE-ECLAMPSIA; PREGNANCY; VITAMIN B 12;

EID: 84937542647     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.July.17.10     Document Type: Article

References (14)

1. Buurma A, Cohen D, Veraar K, Schonkeren D, et al. (2012). Preeclampsia is characterized by placental complement dysregulation. Hypertension 60: 1332-1337.
2. Ingrosso D and Perna AF (2009). Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim. Biophys. Acta. 1790: 892-899.
3. James JL, Whitley GS and Cartwright JE (2010). Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J. Pathol. 221: 363-378.
4. Kanasaki K and Kalluri R (2009). The biology of preeclampsia. Kidney Int. 76: 831-837.
5. Klai S, Fekih-Mrissa N, El Housaini S, Kaabechi N, et al. (2011). Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies. Blood Coagul. Fibrinolysis 22: 374-378.
6. Kulkarni A, Chavan-Gautam P, Mehendale S, Yadav H, et al. (2011). Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol. 30: 79-84
7. Le J (2008). Obstetrics and Gynecology. 7th edn. (Le J, eds.). People’s Medical Publishing House, Beijing, 92-99.
8. Mao D, Che J, Li K, Han S, et al. (2010). Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia. Arch. Gynecol. Obstet. 282: 371-375.
9. McCabe MT, Brandes JC and Vertino PM (2009). Cancer DNA methylation: molecular mechanisms and clinical implications. Clin. Cancer Res. 15: 3927-3937.
10. Steed MM, Tyagi N, Moshal K and Tyagi SC (2007). Homocysteine and Oxidative Mechanisms of Vascular Remodeling. FASEB J. 21: 897.25 (Meeting abstract).
11. Wang L, Zhang J and Wang S (2007). Demethylation in the promoter region of MTHFR gene and its mRNA expression in cultured human vascular smooth muscle cells induced by homocysteine. Wei Sheng Yan Jiu. 36: 291-294.
12. Xia XP, Chang WW and Cao YX (2012). Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to pre-eclampsia. Hypertens Res. 35: 1129-1134
13. Yi B, Zhang H and Huang ZJ (2008). Co-injury effects of advanced glycation end products and homocysteine on endothelial cells. China J. Modern Med. 18: 1552-1556.
14. Zhou W, Chai H, Courson A, Lin PH, et al. (2006). Ginkgolide A attenuates homocysteine-induced endothelial dysfunction in porcine coronary arteries. J. Vasc. Surg. 44: 853-862.